Levy Howard 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jan 27, 2020
Insider Transaction Report
Form 4
Levy Howard
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-01-23+45,000→ 45,000 totalExercise: $6.85Exp: 2030-01-23→ Common Stock (45,000 underlying)
Footnotes (1)
- [F1]Award vests over a four (4) year period on each monthly anniversary commencing January 23, 2020.